Iridian Asset Management LLC CT Has $869,000 Stake in Molina Healthcare, Inc. (NYSE:MOH)

Iridian Asset Management LLC CT decreased its holdings in Molina Healthcare, Inc. (NYSE:MOH) by 16.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,522 shares of the company’s stock after selling 500 shares during the period. Iridian Asset Management LLC CT’s holdings in Molina Healthcare were worth $869,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in the business. Quent Capital LLC grew its stake in shares of Molina Healthcare by 6.8% in the 1st quarter. Quent Capital LLC now owns 489 shares of the company’s stock valued at $201,000 after buying an additional 31 shares in the last quarter. Custom Index Systems LLC grew its stake in shares of Molina Healthcare by 5.0% in the 2nd quarter. Custom Index Systems LLC now owns 690 shares of the company’s stock valued at $205,000 after buying an additional 33 shares in the last quarter. AlphaMark Advisors LLC grew its stake in shares of Molina Healthcare by 1.1% in the 2nd quarter. AlphaMark Advisors LLC now owns 3,543 shares of the company’s stock valued at $1,053,000 after buying an additional 40 shares in the last quarter. Oliver Luxxe Assets LLC grew its stake in shares of Molina Healthcare by 1.3% in the 3rd quarter. Oliver Luxxe Assets LLC now owns 4,428 shares of the company’s stock valued at $1,526,000 after buying an additional 55 shares in the last quarter. Finally, Arizona State Retirement System grew its stake in shares of Molina Healthcare by 0.4% in the 2nd quarter. Arizona State Retirement System now owns 16,092 shares of the company’s stock valued at $4,784,000 after buying an additional 57 shares in the last quarter. Institutional investors and hedge funds own 98.50% of the company’s stock.

Molina Healthcare Stock Performance

Shares of NYSE MOH opened at $324.24 on Thursday. The business has a fifty day simple moving average of $334.11 and a 200 day simple moving average of $328.58. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.49. The firm has a market capitalization of $19.00 billion, a price-to-earnings ratio of 17.77, a PEG ratio of 0.99 and a beta of 0.58. Molina Healthcare, Inc. has a one year low of $272.69 and a one year high of $423.92.

Molina Healthcare (NYSE:MOH) last issued its earnings results on Wednesday, October 23rd. The company reported $6.01 EPS for the quarter, beating analysts’ consensus estimates of $5.96 by $0.05. The business had revenue of $10.34 billion during the quarter, compared to analyst estimates of $9.92 billion. Molina Healthcare had a return on equity of 28.09% and a net margin of 2.84%. Molina Healthcare’s revenue was up 21.0% on a year-over-year basis. During the same period in the prior year, the company posted $5.05 earnings per share. Sell-side analysts expect that Molina Healthcare, Inc. will post 23.5 EPS for the current year.

Insiders Place Their Bets

In other Molina Healthcare news, CAO Maurice Hebert sold 393 shares of the stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $346.52, for a total transaction of $136,182.36. Following the completion of the transaction, the chief accounting officer now directly owns 9,473 shares in the company, valued at $3,282,583.96. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 1.10% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently commented on the company. Wells Fargo & Company boosted their price target on Molina Healthcare from $315.00 to $360.00 and gave the company an “equal weight” rating in a research note on Monday, August 5th. TD Cowen decreased their target price on Molina Healthcare from $412.00 to $351.00 and set a “buy” rating for the company in a research report on Wednesday, July 24th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $406.00 target price on shares of Molina Healthcare in a research report on Thursday, October 24th. Jefferies Financial Group decreased their target price on Molina Healthcare from $354.00 to $297.00 and set a “hold” rating for the company in a research report on Wednesday, July 24th. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on Molina Healthcare from $354.00 to $353.00 and set a “hold” rating for the company in a research report on Monday, July 29th. One research analyst has rated the stock with a sell rating, six have issued a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $367.00.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.